Extract notice to the Minister

NAT-Sunitinib

Common name / Subject : sunitinib (malate de)
Name of the manufacturer : Natco
Form :
Dosage :

Indication :

INESSS' Recommendation
Inscription - Avec conditions

Minister's decisions
Inscrire aux listes des médicaments - Médicament d'exception

Evaluation published on December 11, 2025

Subscribe to our newsletter now

Subscription